Home
Thomas Andrew Crockett, CEO: KalVista Pharmaceuticals KALV Sell · Filed 24/02/16
Trade details
- Type
- Insider sale
- Amount
- $875,923.56
- Shares · price
- 58,356 sh · $15.01 a share
- Held after
- 181,676 sh
- Trade date
- 24/02/14
- Filed
- 24/02/16
- Days to filing
- 2 days
Sold 24.3% of holdings
- Share of holding sold
- 24.3%
KalVista Pharmaceuticals trades, last 26 weeks
What else happened in KalVista Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 24/01/15~24/03/15Thomas Andrew Crockett's recent trades
- Thomas Andrew Crockett
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$351.2K
24,888 sh
$351.2K
Filed 24/02/21
Traded 24/02/20
- Thomas Andrew Crockett
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$150.5K
9,300 sh
$150.5K
Filed 24/02/05
Traded 24/02/01
- Thomas Andrew Crockett
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$11.8K
700 sh
$11.8K
Filed 24/02/05
Traded 24/02/01
- Thomas Andrew Crockett
Sell10b5-1 planKalVista Pharmaceuticals
Sell10b5-1 planKalVista Pharmaceuticals
KALV
$360.6K
30,000 sh
$360.6K
Filed 23/12/28
Traded 23/12/27
- Thomas Andrew Crockett
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$121.9K
14,807 sh
$121.9K
Filed 23/11/21
Traded 23/11/20